-
Dr. Huichuan Sun: Focusing on the Asia-Pacific Region, Leading the Frontier – Exploring Breakthroughs in the Treatment of Hepatobiliary Tumor
-
Dr. Zhaochong Zeng: Enhancing Efficiency and Reducing Burden – Latest Advances in Radiotherapy for Liver Cancer Treatment
-
Congratulations! Dr. Jian Zhou has been elected as the President-elect of the Asia-Pacific Primary Liver Cancer Expert Alliance (APPLE)
-
Dr. Gong Li: Combined Radiotherapy, Anti-Angiogenic Medication, and Immunotherapy for Downstaging Treatment in Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombus
-
Dr.Wai-Kay Seto: Balancing the Risks and Benefits of Long-Term HBV Treatment
-
Dr. Masatoshi Kudo: Does the Treatment Paradigm for Intermediate HCC Need to Change?
-
Dr. Kathryn J. Fowler: When to Consider Biopsy – Radiologist’s Perspective
-
APPLE 2023 | Combining KRAS inhibitors may enhance immunotherapeutic response in liver cancer patients
-
Dr. Hanchong Toh: Promising Prospects for Immune Adjuvant Therapy in Liver Cancer
Connecting Medical Expertise through Media